Honestly, and no joking here, I wouldn't touch this stock at anything above 1.5c
Look up how much it costs from clinical pre-trials to Phase 1.
It's frightening - and Nyrada has nowhere near enough funds to even think about going it alone.
JV seems logical as the pathway - but I would need to see how much dilution was involved first.
This isn't like MSB Roch - it's cost them 20 yrs and billions of $$$ to get to pre-approval stage for Ryoncil.
My buy in there was 40c.
Here, at pre-stage 1 it's 1.5c
Anything higher and the RRR is poor. Very poor.
Ann: NYR Signs Strategic Partnership with US Brain Injury Company, page-41
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.3¢ |
Change
0.003(2.50%) |
Mkt cap ! $19.13M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.0¢ | 10.0¢ | $60.96K | 584.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 49724 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 50000 | 2 |
View Market Depth
| Last trade - 14.27pm 07/10/2024 (20 minute delay) ? |
| NYR (ASX) Chart |